Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

NCT01567306 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis

Interventions

BIOLOGICAL: Allergovac Depot
BIOLOGICAL: Allergovac Depot
BIOLOGICAL: Allergovac Depot
BIOLOGICAL: Allergovac Depot
BIOLOGICAL: Allergovac Depot
BIOLOGICAL: Placebo

Sponsor

Roxall Medicina España S.A